BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JY, Kim N, Park JH, Nam RH, Lee SM, Song CH, Kim G, Na HY, Choi YJ, Kim JJ, Lee DH. Expression of Neurotrophic Factors, Tight Junction Proteins, and Cytokines According to the Irritable Bowel Syndrome Subtype and Sex. J Neurogastroenterol Motil 2020;26:106-16. [PMID: 31623029 DOI: 10.5056/jnm19099] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Choi Y, Choi SI, Kim N, Nam RH, Jang JY, Na HY, Shin CM, Lee DH, Min H, Kim YR, Seok YJ. Effect of Clostridium butyricum on High-Fat Diet-Induced Intestinal Inflammation and Production of Short-Chain Fatty Acids. Dig Dis Sci 2023. [PMID: 36670324 DOI: 10.1007/s10620-023-07835-2] [Reference Citation Analysis]
2 Choi S, Kim N, Park JH, Nam RH, Song CH, Lee HS. Effect of Helicobacter pylori infection and its eradication on the expression of tight junction proteins in the gastric epithelium in relation to gastric carcinogenesis. Helicobacter 2022;27:e12929. [PMID: 36063450 DOI: 10.1111/hel.12929] [Reference Citation Analysis]
3 Pushkina AV, Avalueva EB, Bakulin IG, Topanova AA, Klikunova KA, Lapinskii IV, Sitkin SI. Risk factors for various clinical variants of irritable bowel syndrome. jour 2022. [DOI: 10.31146/1682-8658-ecg-201-5-39-48] [Reference Citation Analysis]
4 Tao E, Zhu Z, Hu C, Long G, Chen B, Guo R, Fang M, Jiang M. Potential Roles of Enterochromaffin Cells in Early Life Stress-Induced Irritable Bowel Syndrome. Front Cell Neurosci 2022;16:837166. [DOI: 10.3389/fncel.2022.837166] [Reference Citation Analysis]
5 Samy W, El Gebaly A, Ahmed NH, Talaat A. Ghrelin polymorphism/TRPV1 receptor expression in Egyptian IBS patients. Cytokine 2022;152:155827. [PMID: 35182895 DOI: 10.1016/j.cyto.2022.155827] [Reference Citation Analysis]
6 El-haggar SM, Hegazy SK, Abd-elsalam SM, Elkaeed EB, Al-karmalawy AA, Bahaa MM. A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial. JIR 2022;Volume 15:1159-72. [DOI: 10.2147/jir.s346608] [Reference Citation Analysis]
7 Pretorius L, Van Staden ADP, Van der Merwe JJ, Henning N, Smith C. Alterations to microbial secretome by estrogen may contribute to sex bias in irritable bowel syndrome. Inflammopharmacology 2022. [PMID: 35022916 DOI: 10.1007/s10787-021-00906-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kim N. Irritable Bowel Syndrome. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases 2022. [DOI: 10.1007/978-981-19-0120-1_16] [Reference Citation Analysis]
9 El-Haggar SM, Hegazy SK, M Abd-Elsalam S, Bahaa MM. Open-label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome. J Clin Pharm Ther 2021. [PMID: 34726293 DOI: 10.1111/jcpt.13556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Meira de-Faria F, Casado-Bedmar M, Mårten Lindqvist C, Jones MP, Walter SA, Keita ÅV. Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome. Neurogastroenterol Motil 2021;33:e14130. [PMID: 33797165 DOI: 10.1111/nmo.14130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Zeng J, Yu H, Gan HT. Glial cell line-derived neurotrophic factor ameliorates dextran sulfate sodium-induced colitis in mice via a macrophage-mediated pathway. Int Immunopharmacol 2021;100:108143. [PMID: 34543979 DOI: 10.1016/j.intimp.2021.108143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lee SM, Kim N, Yoon H, Kim YS, Choi SI, Park JH, Lee DH. Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients. Gut Liver 2021;15:253-61. [PMID: 32457278 DOI: 10.5009/gnl19379] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
13 Daliri EB, Ofosu FK, Xiuqin C, Chelliah R, Oh DH. Probiotic Effector Compounds: Current Knowledge and Future Perspectives. Front Microbiol 2021;12:655705. [PMID: 33746935 DOI: 10.3389/fmicb.2021.655705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Hanning N, Edwinson AL, Ceuleers H, Peters SA, De Man JG, Hassett LC, De Winter BY, Grover M. Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review. Therap Adv Gastroenterol 2021;14:1756284821993586. [PMID: 33717210 DOI: 10.1177/1756284821993586] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 14.0] [Reference Citation Analysis]
15 Kamp KJ, Han C, Shulman RJ, Cain KC, Barney P, Opp MR, Chang L, Burr RL, Heitkemper MM. Cytokine Levels and Symptoms Among Women with Irritable Bowel Syndrome: Considering the Role of Hormonal Contraceptive Use. Biol Res Nurs 2021;23:171-9. [PMID: 32677464 DOI: 10.1177/1099800420941252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Lee JY, Kim N, Choi YJ, Park JH, Ashktorab H, Smoot DT, Lee DH. Expression of Tight Junction Proteins According to Functional Dyspepsia Subtype and Sex. J Neurogastroenterol Motil 2020;26:248-58. [PMID: 32235032 DOI: 10.5056/jnm19208] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]